Modern Systemic Therapy for Metastatic Renal Cell Carcinoma of the Clear Cell Type von Parikh, Mamta, Lara, Primo N

Volltext

New and emerging developments in extensive-stage small cell lung cancer therapeutics von Parikh, Mamta, Riess, Jonathan, Lara, Primo N

Volltext

Novel inhibition of AKR1C3 and androgen receptor axis by PTUPB synergizes enzalutamide treatment in advanced prostate cancer von Yang, Joy C., Xu, Pengfei, Ning, Shu, Wasielewski, Logan J., Adomat, Hans, Hwang, Sung Hee, Morisseau, Christophe, Gleave, Martin, Corey, Eva, Gao, Allen C., Lara Jr, Primo N., Evans, Christopher P., Hammock, Bruce D., Liu, Chengfei

Volltext

Adjuvant everolimus after renal cell carcinoma nephrectomy – Authors' reply von Ryan, Christopher W, Tangen, Catherine M, Lara, Primo N

Volltext

Progress in Personalizing Chemotherapy for Bladder Cancer von Chang, James S., Lara, Primo N., Pan, Chong-Xian

Volltext

Left Behind? Drug Discovery in Extensive-Stage Small-Cell Lung Cancer von Riess, Jonathan W, Lara, Primo N

Volltext

Theory Meets Practice for Immune Checkpoint Blockade in Small-Cell Lung Cancer von Riess, Jonathan W, Lara, Jr, Primo N, Gandara, David R

Volltext

Patient-Derived Xenografts for Investigation of Acquired Resistance in Oncogene-Driven Cancers: Building a Better Mousetrap von Gandara, David R, Lara, Jr, Primo N, Mack, Philip C

Volltext

Docetaxel in non-small cell lung cancer: a review von Davies, Angela M, Lara Jr, Primo N, Mack, Philip C, Gandara, David R

Volltext

Small-cell carcinoma of the urinary bladder: diagnosis and management von Pan, Chong-xian, Zhang, Hongyong, Lara Jr, Primo N, Cheng, Liang

Volltext

Renal-Cell Cancer — Targeting an Immune Checkpoint or Multiple Kinases von Quinn, David I, Lara, Primo N

Volltext

Papillary Renal Cell Carcinoma: Current Progress and Future Directions von Twardowski, Przemyslaw W, Mack, Philip C, Lara, Primo N

Volltext

Kidney Cancer Incidence in California: End of the Trend? von Morris, Cyllene R., Lara, Primo N., Parikh-Patel, Arti, Kizer, Kenneth W.

Volltext

Metabolic reprogramming in clear cell renal cell carcinoma von Wettersten, Hiromi I., Aboud, Omran Abu, Lara, Primo N., Weiss, Robert H.

Volltext

Evolving Epidemiologic Trends in Nonclear Cell Renal Cell Cancer: An Analysis of the California Cancer Registry von Pai, Ashok, Brunson, Ann, Brown, Monica, Pan, Chong-Xian, Lara, Primo N

Volltext

Molecular selection for therapy of patients with non-small-cell lung cancer and impaired performance status: has the time come? von Lara, Jr, Primo N

Volltext

A comparison of sunitinib with cabozantinib, crizotinib, and savolitinib for treatment of advanced papillary renal cell carcinoma: a randomised, open-label, phase 2 trial von Pal, Sumanta K, Tangen, Catherine, Thompson, Ian M, Balzer-Haas, Naomi, George, Daniel J, Heng, Daniel Y C, Shuch, Brian, Stein, Mark, Tretiakova, Maria, Humphrey, Peter, Adeniran, Adebowale, Narayan, Vivek, Bjarnason, Georg A, Vaishampayan, Ulka, Alva, Ajjai, Zhang, Tian, Cole, Scott, Plets, Melissa, Wright, John, Lara, Primo N

Volltext

Adjuvant Therapy in Completely Resected Malignant Thymoma von Lara, Primo N.

Volltext

Dasatinib and docetaxel in advanced prostate cancer von Lara, Primo N, Evans, Christopher P

Volltext

Kidney Cancer: A New Forum for Impactful Scientific Interactions von Lara, Primo N., Mulders, Peter F.A.

Volltext